Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Influence of high glucose and advanced glycation end-products (ages) levels in human osteoblast-like cells gene expression

Fig. 1

Gene expression of RUNX2 a OSX b and AGER c Osteoblasts from OA patients (n = 10), OP patients (n = 10) and T2DM patients (n = 12) were treated with low glucose as control (4.5 mM; Glu), high glucose (25 mM; HGlu) and high glucose + AGEs (2 μg/ml; HGlu + AGEs) during 24 h. The results were normalized to 18S ribosomal and adjusted for age in the statistical analyses. The data is expressed as mean ± SEM (relative units). (*statistically significant at p < 0.05)

Back to article page